Russian scientists develop groundbreaking stem cell-based drug to treat brain damage after strokes

Russian researchers have announced a significant breakthrough in the treatment of acute brain injuries, including strokes. A new drug uses stem cell-derived secretions to stimulate brain recovery and reduce neurological damage. This is reported by Emirates News Agency (WAM), a partner of TV BRICS.

According to experts, the therapy is designed to target all types of strokes and has shown promising results in preclinical trials. The treatment works by significantly reducing cerebral haemorrhage and protecting affected neural tissues in the early stages following a stroke, making it a potential first-line intervention during the critical phase of patient care.

The newly developed drug leverages the therapeutic potential of mesenchymal stromal cells to tackle multiple aspects of brain injury in one approach.

The research team highlighted that the cell secretions promote neuroprotection, modulate inflammation, and enhance repair mechanisms within the damaged brain regions. These findings suggest a pathway for developing comprehensive treatments that could significantly improve outcomes for stroke patients worldwide.

Photo: iStock